Recombinant phospholipase A1 (Ves v 1) from yellow jacket venom for improved diagnosis of hymenoptera venom hypersensitivity
Open Access
- 1 April 2010
- journal article
- Published by Springer Science and Business Media LLC in Clinical and Molecular Allergy
- Vol. 8 (1), 7
- https://doi.org/10.1186/1476-7961-8-7
Abstract
Background Hymenoptera venoms are known to cause life-threatening IgE-mediated anaphylactic reactions in allergic individuals. Proper diagnosis of hymenoptera venom allergy using venom extracts is severely affected by molecular cross-reactivities. Although non-glycosylated marker allergens would facilitate the identification of the culprit venom, the major allergen phospholipase A1 (Ves v 1) from yellow jacket venom (YJV) remained unavailable so far. Methods Expression of Ves v 1 as wild type and enzymatically inactivated mutant and Ves v 5 in insect cells yielded soluble proteins that were purified via affinity chromatography. Functionality of the recombinant allergens was assessed by enzymatic and biophysical analyses as well as basophil activation tests. Diagnostic relevance was addressed by ELISA-based analyses of sera of YJV-sensitized patients. Results Both major allergens Ves v 1 and Ves v 5 could be produced in insect cells in secreted soluble form. The recombinant proteins exhibited their particular biochemical and functional characteristics and were capable for activation of human basophils. Assessment of IgE reactivity of sera of YJV-sensitized and double-sensitized patients emphasised the relevance of Ves v 1 in hymenoptera venom allergy. In contrast to the use of singular molecules the combined use of both molecules enabled a reliable assignment of sensitisation to YJV for more than 90% of double-sensitised patients. Conclusions The recombinant availability of Ves v 1 from yellow jacket venom will contribute to a more detailed understanding of the molecular and allergological mechanisms of insect venoms and may provide a valuable tool for diagnostic and therapeutic approaches in hymenoptera venom allergy.Keywords
This publication has 20 references indexed in Scilit:
- Identification, Recombinant Expression, and Characterization of the 100 kDa High Molecular Weight Hymenoptera Venom Allergens Api m 5 and Ves v 3Published by The American Association of Immunologists ,2010
- Dissecting cross-reactivity in hymenoptera venom allergy by circumvention of α-1,3-core fucosylationMolecular Immunology, 2009
- Kreuzreaktivität auf Bienen- und WespengiftDie Dermatologie, 2008
- Diagnosis of Hymenoptera venom allergyAllergy, 2005
- Recent developments and future strategies for immunotherapy of insect venom allergyCurrent Opinion in Allergy and Clinical Immunology, 2003
- Recombinant Hymenoptera venom allergensAllergy, 2002
- Structure and Biology of Stinging Insect Venom AllergensInternational Archives of Allergy and Immunology, 2000
- Expression of yellow jacket and wasp venom Ag5 allergens in bacteria and in yeast.1999
- Yellow jacket venom allergens, hyaluronidase and phospholipase: Sequence similarity and antigenic cross-reactivity with their hornet and wasp homologs and possible implications for clinical allergy☆, ☆☆, ★, ★★Journal of Allergy and Clinical Immunology, 1996
- Immunochemical studies of yellowjacket venom proteinsMolecular Immunology, 1983